News from
BayBG Venture Capital

BayBG Venture Capital successfully exits AMW, a specialty pharma company for biodegradable drug delivery systems. Ren Life Sciences and Juno Capital Partners become new majority shareholders as AMW enters its next growth phase.

The Munich VC community kicked off the new year at the Venture Capital Kickoff 2026, bringing together nearly 200 startups, investors, and key ecosystem players.

We’re proud to continue our partnership with AlfaDocs – the patient-first cloud platform transforming the digitalization of medical and dental practices in Europe.

Corsair Capital acquired a majority stake and enables digital identity leader IDnow to enter next stage of growth and innovation

The Munich VC scene came together once again for the traditional Venture Capital Kick-off hosted at BayBG. More than 200 startups, investors, and key players gathered for this collaborative event organized by BayBG, Cipio Partners, VC Magazin, and the law firm WIPIT.

Dcubed secures over-subscribed Series A round investment – to scale production, pioneer in-space manufacturing, and extend U.S. footprint